Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Unraveling the genetics of transformed splenic marginal zone lymphoma.
Grau M, López C, Navarro A, Frigola G, Nadeu F, Clot G, Bastidas-Mora G, Alcoceba M, Baptista MJ, Blanes M, Colomer D, Costa D, Domingo-Domènech E, Enjuanes A, Escoda L, Forcada P, Giné E, Lopez-Guerra M, Ramón O, Rivas-Delgado A, Vicente Folch L, Wotherspoon A, Climent F, Campo E, López-Guillermo A, Matutes E, Beà S. Grau M, et al. Blood Adv. 2023 Jul 25;7(14):3695-3709. doi: 10.1182/bloodadvances.2022009415. Blood Adv. 2023. PMID: 36995085 Free PMC article.
Peripheral T-cell lymphoma with a T follicular-helper phenotype: A different entity? Results of the Spanish Real-T study.
Martín García-Sancho A, Rodríguez-Pinilla SM, Domingo-Domenech E, Climent F, Sánchez-Garcia J, López Jiménez J, García-Cosío Piqueras M, Castellvi J, González AJ, González de Villambrosia S, Gómez Codina J, Navarro B, Rodríguez G, Borrero JJ, Fraga M, Naves A, Baeza L, Córdoba R. Martín García-Sancho A, et al. Among authors: domingo domenech e. Br J Haematol. 2023 Oct;203(2):182-193. doi: 10.1111/bjh.18941. Epub 2023 Jun 30. Br J Haematol. 2023. PMID: 37386897
Impact of pre- and/or post-autologous stem cell transplantation exposure to brentuximab vedotin on survival outcomes in patients with high-risk Hodgkin lymphoma.
Martínez C, de Haro ME, Romero S, Gutiérrez A, Domingo-Domènech E, González-Rodríguez AP, Zeberio I, Martínez-Badas MP, Rodríguez-Izquierdo A, Carpio C, Bastos-Oreiro M, Hernández-Rivas JÁ, Vallansot R, Kelleher N, Díaz-Gálvez FJ, Torrado T, Pereira A, García-Sanz R; Grupo Español de Linfoma y Trasplante de Médula Ósea (GELTAMO) y Grupo Español de Trasplante (GETH). Martínez C, et al. Ann Hematol. 2023 Feb;102(2):429-437. doi: 10.1007/s00277-022-05011-6. Epub 2022 Nov 12. Ann Hematol. 2023. PMID: 36370191 Free article.
Indolent course as presentation in t-prolymphocytic leukaemia.
Domingo-Domènech E, González-Barca E, Salar A, Clarós AD, Grañena A. Domingo-Domènech E, et al. Br J Haematol. 1999 Jun;105(3):840. doi: 10.1046/j.1365-2141.1999.01485.x. Br J Haematol. 1999. PMID: 10354157 Free article. No abstract available.
Prospective study of prognostic factors in asymptomatic patients with B-cell chronic lymphocytic leukemia-like lymphocytosis: the cut-off of 11 × 10(9)/L monoclonal lymphocytes better identifies subgroups with different outcomes.
Oliveira AC, Fernández de Sevilla A, Domingo A, De La Banda E, Domingo-Domènech E, Mercadal S, Ruiz-Xivillé N, Alonso E, Encuentra M, González-Barca E. Oliveira AC, et al. Ann Hematol. 2015 Apr;94(4):627-32. doi: 10.1007/s00277-014-2263-1. Epub 2014 Dec 5. Ann Hematol. 2015. PMID: 25471173
99 results